Table 3. Summary of the risk ration (RR) of treatment-related adverse events between liraglutide added to metformin and other therapies.
| Adverse events | RR | 95%CI | P value |
|---|---|---|---|
| Nausea | 2.26 | 0.98, 5.25 | 0.057 |
| Diarrhea | 1.98 | 1.30, 3.00 | 0.001 |
| Vomiting | 1.62 | 0.94, 2.79 | 0.080 |
| Dyspepsia | 1.31 | 0.69, 2.52 | 0.411 |
| Constipation | 1.17 | 0.80, 1.69 | 0.424 |
| Nasopharyngitis | 0.89 | 0.65, 1.22 | 0.471 |
| Headache | 1.12 | 0.85, 1.47 | 0.419 |
| Back pain | 1.36 | 0.64, 2.91 | 0.430 |
| Deceased appetite | 1.25 | 0.66, 2.36 | 0.499 |
| Influenza | 1.90 | 0.90, 4.03 | 0.092 |
| Hypoglycemia | 0.33 | 0.08, 1.44 | 0.140 |
Abbreviations: CI, confidence interval.